🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.

Several experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Product Details and Costs

Inside these groups, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.